Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
- To evaluate the safety and tolerability of TMC435 in combination with pegylated interferon alpha-2a (PegIFNα- 2a)/ribavirin (RBV) in HCV genotype-1 infected subjects, co-infected with HIV-1. - To evaluate the proportion of subjects with sustained virologic response (SVR) 24 weeks after the planned end of treatment (SVR24).
Critère d'inclusion
- Hepatitis C and co-infected with HIV